Medclair Invest AB
Medclair Invest, has through its wholly owned subsidiary Medclair AB, developed patented technologies to measure, collect and destruct nitrous oxide. The product portfolio consists of five complementary products covering today’s need in healthcare. The company’s technology, patents and expertise enable expansion into other areas over time.
Equity Research, Medclair
December, 1 2021 Investment case: Expected breakthrough for Greentech company